ClinicalTrials HQ

A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.

A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.

Active, not recruiting · NCT05064878 · Registry updated 2026-04-29
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.Epilepsy, Generalized, Epileptic Syndromes, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spasms, Infantile, brain disorder, central nervous system disorder, epilepsy, epilepsy with generalized tonic-clonic seizures, nervous system disorder, visual epilepsyActive, not recruitingPhase 32026-04-29NCT05064878

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Zogenix, Inc.1

46 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ep0216 101San FranciscoUnited States1
Ep0216 1103BarcelonaSpain1
Ep0216 1117MadridSpain1
Ep0216 1118Santiago de CompostelaSpain1
Ep0216 113BrooklineUnited States1
Ep0216 120PhiladelphiaUnited States1
Ep0216 1201FlorenceItaly1
Ep0216 1202VeronaItaly1
Ep0216 1204GenovaItaly1
Ep0216 1206RomaItaly1
Ep0216 1208RomaItaly1
Ep0216 1212ModenaItaly1
Ep0216 124MemphisUnited States1
Ep0216 134DetroitUnited States1
Ep0216 1401ZwolleNetherlands1
Ep0216 144Los AngelesUnited States1
Ep0216 149Washington D.C.United States1
Ep0216 1502ShizuokaJapan1
Ep0216 1505NiigataJapan1
Ep0216 1512HiroshimaJapan1
Ep0216 1518Omura-shiJapan1
Ep0216 154BirminghamUnited States1
Ep0216 157AtlantaUnited States1
Ep0216 164ClevelandUnited States1
Ep0216 166Chapel HillUnited States1